Mary Joan Hampson-Carlin
Corporate Officer/Principal chez Laureate Biopharmaceutical Services, Inc.
Profil
Mary Joan Hampson-Carlin is currently the Vice President-Quality Systems at Laureate Biopharmaceutical Services, Inc. She completed her undergraduate degree at Quinnipiac University and her MBA at the University of New Haven.
Postes actifs de Mary Joan Hampson-Carlin
| Sociétés | Poste | Début |
|---|---|---|
Laureate Biopharmaceutical Services, Inc.
 Laureate Biopharmaceutical Services, Inc. Pharmaceuticals: MajorHealth Technology Laureate Biopharmaceutical Services, Inc. provides biopharmaceutical development and protein production services. It offers product development and manufacturing services from cell line optimization and process design to development of full-scale cGMP protein production, purification and aseptic filling, in addition to corresponding testing, validation, analytical and regulatory support. The firm's focus is on mammalian cell based monoclonal antibody and recombinant protein production for clinical and modest commercial supply. The company was founded in 1981 and is headquartered in Princeton, NJ. | Corporate Officer/Principal | 31/07/2009 |
Formation de Mary Joan Hampson-Carlin
| Quinnipiac University | Undergraduate Degree |
| University of New Haven | Masters Business Admin |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Laureate Biopharmaceutical Services, Inc.
Laureate Biopharmaceutical Services, Inc. Pharmaceuticals: MajorHealth Technology Laureate Biopharmaceutical Services, Inc. provides biopharmaceutical development and protein production services. It offers product development and manufacturing services from cell line optimization and process design to development of full-scale cGMP protein production, purification and aseptic filling, in addition to corresponding testing, validation, analytical and regulatory support. The firm's focus is on mammalian cell based monoclonal antibody and recombinant protein production for clinical and modest commercial supply. The company was founded in 1981 and is headquartered in Princeton, NJ. | Health Technology |
